期刊文献+

linagliptin与靶标DPP4作用机理及分子设计研究 被引量:1

Theoretical Studies on Interactions of linagliptin and DPP4
下载PDF
导出
摘要 采用分子对接方法对目前刚刚上市的糖尿病抑制剂linagliptin与其靶标DDP4进行研究,建立了合理、有效的对接模型,获得了其活性口袋周围的环境分布情况。并根据这些结论进行了分子设计,对理论设计的新分子通过已建立的模型进行预测,其结果显示它具有比linagliptin更好的对接结合能。该研究结果可为实验工作者合成新药提供理论参考。 The molecular docking method was used to study the interactions linagliptin and DPP4. A reliable and ef- fective model was established. Based on the above regularities, three new molecules with higher energy of docking were theoretically designed and waiting for the support from experiment. These results can offer a theoretical reference for the pharmaceutical synthesis.
出处 《广州化工》 CAS 2013年第5期13-14,23,共3页 GuangZhou Chemical Industry
基金 广西教育厅科研项目(201010LX373 201106LX441 200103YB114) 百色市科学局(1001014)
关键词 DPP4 DOCK 维格列汀 分子设计 linagliptin DPP4 Dock molecular design
  • 相关文献

参考文献4

二级参考文献51

  • 1Goke B.Islet cell function:alpha and beta cells-partners towards normoglycaemia.Int J Clin Pract Suppl,2008,(159):2-7.
  • 2Kim MH,Lee MK.The incretins and pancreatic beta-cells:use of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide to cure type 2 diabetes Mellitus.Korean Diabetes J,2010,34:2-9.
  • 3Kim W,Egan JM.The role of incretins in glucose homeostasis and diabetes treatment.Pharmacol Rev,2008,60:470-512.
  • 4Neumiller JJ,Wood L,Campbell RK.Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus.Pharmacotherapy,2010,30:463-484.
  • 5Deacon CF.Circulation and degradation of GIP and GLP-1.Horm Metab Res,2004,36:761-765.
  • 6Deacon CF,Carr RD,Holst JJ.DPP-4 inhibitor therapy:new directions in the treatment of type 2 diabetes.Front Biosci,2008,13:1780-1794.
  • 7Lankas GR,Leiting B,Roy RS,et al.Dipeptidyl peptidase Ⅳ inhibition for the treatment of type 2 diabetes:potential importance of selectivity over dipeptidyl peptidases 8 and 9.Diabetes,2005,54:2988 -2994.
  • 8Holst JJ,Deacon CF.Inhibition of the activity of dipeptidyl-peptidase Ⅳ as a treatment for type 2 diabetes.Diabetes,1998,47:1663-1670.
  • 9Ahren B,Holst JJ,Martensson H,et al.Improved glucose tolerance and insulin secretion by inhibition of dipeptidyl peptidase Ⅳ in mice.Eur J Pharmacol,2000,404:239-245.
  • 10Mari A,Sallas WM,He YL,et al.Vildagliptin,a dipeptidyl peptidase-Ⅳ inhibitor,improves model-assessed beta-cell function in patients with type 2 diabetes.J Clin Endocrinol Metab,2005,90:4888-4894.

共引文献124

同被引文献6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部